SCHEMBL18907239

SCHEMBL18907239

c1ccc2cc3c(cc2c1)oc1c(-c2c4ccccc4c(-c4nc5c6ccccc6ccc5c5c4ccc4ccccc45)c4ccccc24)cc2ccccc2c13

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP1A2 P05177 3/20 0.31
CYP1A1 P04798 1/20 0.31
FYN P06241 1/20 0.31
MAPK3 P27361 1/20 0.31
AHR P35869 1/20 0.31
PAX8 Q06710 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
MAOA P21397 1/20 0.31
MAPT P10636 1/20 0.30
NPC1 O15118 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
RAB9A P51151 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18907226 0.90 TDP1 (0.35) SOS1L3MBTL1TDP1KDM4EMEN1
SCHEMBL18907405 0.89 SOS1 (0.34) SOS1L3MBTL1TDP1KDM4EMEN1
SCHEMBL18907256 0.89 CYP1A1 (0.33) SOS1L3MBTL1TDP1KDM4EMEN1
SCHEMBL17737528 0.83 MEN1 (0.37) SOS1L3MBTL1KDM4EMEN1KMT2A
SCHEMBL18907201 0.83 CYP1A2 (0.34) L3MBTL1TDP1KDM4EMEN1KMT2A
SCHEMBL18842544 0.81 KDM4E (0.34) L3MBTL1TDP1KDM4EMEN1KMT2A
SCHEMBL18907204 0.81 CYP1A1 (0.33) L3MBTL1TDP1KDM4EMEN1KMT2A
SCHEMBL17589501 0.80 TDP1 (0.37) L3MBTL1TDP1KDM4EMEN1KMT2A
SCHEMBL18907181 0.80 CYP1A1 (0.33) L3MBTL1TDP1KDM4EKMT2ACYP1A2
SCHEMBL19627855 0.80 L3MBTL1 (0.33) L3MBTL1TDP1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 SOS1 1728/4885L3MBTL1 2069/4885TDP1 1745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.